| scholarly article | Q13442814 |
| P50 | author | Bjarne Bogen | Q64441612 |
| Grant McFadden | Q88652661 | ||
| P2093 | author name string | Winnie Chan | |
| Masmudur M Rahman | |||
| Ana Lemos de Matos | |||
| Nancy Y Villa | |||
| Christopher Cogle | |||
| Tom Hofland | |||
| Jess-Karan S Dhillon | |||
| Cameron L Lilly | |||
| Haider M Ali | |||
| P2860 | cites work | Evolving paradigms in the treatment of relapsed/refractory multiple myeloma: increased options and increased complexity | Q26771331 |
| A novel mouse model for multiple myeloma (MOPC315.BM) that allows noninvasive spatiotemporal detection of osteolytic disease | Q27329429 | ||
| Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants | Q29619458 | ||
| Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. | Q33498422 | ||
| Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virus | Q33895494 | ||
| How we manage autologous stem cell transplantation for patients with multiple myeloma | Q34019581 | ||
| High-dose therapy and innovative approaches to treatment of multiple myeloma | Q34223215 | ||
| Virotherapy using myxoma virus prevents lethal graft-versus-host disease following xeno-transplantation with primary human hematopoietic stem cells. | Q34384975 | ||
| Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantation | Q34557219 | ||
| Selective reduction of graft-versus-host disease-mediating human T cells by ex vivo treatment with soluble Fas ligand | Q34772303 | ||
| Neutrophils induced licensing of natural killer cells | Q35568172 | ||
| Tumor-infiltrating neutrophils in pancreatic neoplasia | Q35583287 | ||
| M135R is a novel cell surface virulence factor of myxoma virus | Q35634308 | ||
| Myxoma virus suppresses proliferation of activated T lymphocytes yet permits oncolytic virus transfer to cancer cells | Q35724025 | ||
| Host MHC class II+ antigen-presenting cells and CD4 cells are required for CD8-mediated graft-versus-leukemia responses following delayed donor leukocyte infusions | Q35849099 | ||
| Myxoma virus sensitizes cancer cells to gemcitabine and is an effective oncolytic virotherapeutic in models of disseminated pancreatic cancer | Q35876172 | ||
| Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression | Q36213700 | ||
| Ex vivo virotherapy with myxoma virus does not impair hematopoietic stem and progenitor cells | Q36565516 | ||
| Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer | Q36922264 | ||
| Complete response correlates with long-term survival and progression-free survival in high-dose therapy in multiple myeloma | Q37007113 | ||
| Oncolytic myxoma virus: the path to clinic | Q37126088 | ||
| On the dual roles and polarized phenotypes of neutrophils in tumor development and progression. | Q37907594 | ||
| Beyond consolidation: auto-SCT and immunotherapy for plasma cell myeloma. | Q38370539 | ||
| The Diverse Biological Functions of Neutrophils, Beyond the Defense Against Infections | Q39000116 | ||
| Myxoma and vaccinia viruses bind differentially to human leukocytes | Q39198482 | ||
| Acute myeloid leukemia targeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitro | Q39395568 | ||
| Myxoma Virus Induces Ligand Independent Extrinsic Apoptosis in Human Myeloma Cells | Q39633869 | ||
| Myxoma virus: propagation, purification, quantification, and storage | Q39707862 | ||
| Myxoma virus targets primary human leukemic stem and progenitor cells while sparing normal hematopoietic stem and progenitor cells | Q41052462 | ||
| Expression of the myxoma virus tumor necrosis factor receptor homologue and M11L genes is required to prevent virus-induced apoptosis in infected rabbit T lymphocytes | Q41211877 | ||
| Selective purging of human multiple myeloma cells from autologous stem cell transplantation grafts using oncolytic myxoma virus | Q42144185 | ||
| The addition of tumor necrosis factor plus beta interferon induces a novel synergistic antiviral state against poxviruses in primary human fibroblasts | Q43215263 | ||
| The yin-yang of tumor-associated neutrophils | Q47444009 | ||
| Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo | Q52214749 | ||
| Prognostic value of intratumoral neutrophils in advanced gastric carcinoma in a high-risk area in northern Italy | Q74615771 | ||
| Body condition scoring: a rapid and accurate method for assessing health status in mice | Q77993899 | ||
| Complete remission sustained 3 years from treatment initiation is a powerful surrogate for extended survival in multiple myeloma | Q81251723 | ||
| Graft-versus-host disease | Q83468020 | ||
| P921 | main subject | oncolytic virus | Q1560099 |
| Myxoma virus | Q6949366 | ||
| P304 | page(s) | 31-40 | |
| P577 | publication date | 2016-12-14 | |
| P1433 | published in | Molecular therapy oncolytics | Q27726823 |
| P1476 | title | Ex Vivo Oncolytic Virotherapy with Myxoma Virus Arms Multiple Allogeneic Bone Marrow Transplant Leukocytes to Enhance Graft versus Tumor | |
| P478 | volume | 4 |
| Q97646406 | Autologous Transplantation Using Donor Leukocytes Loaded Ex Vivo with Oncolytic Myxoma Virus Can Eliminate Residual Multiple Myeloma |
| Q38612646 | Fighting Cancer with Mathematics and Viruses |
| Q44837303 | Identification of host DEAD-box RNA helicases that regulate cellular tropism of oncolytic Myxoma virus in human cancer cells |
| Q92633759 | Oncolytic Virotherapy with Myxoma Virus |
| Q89769530 | Oncolytic Viruses and the Immune System: The Dynamic Duo |
| Q55515625 | Oncolytic Viruses for Multiple Myeloma Therapy. |
| Q52674773 | Potential of oncolytic viruses in the treatment of multiple myeloma. |
| Q40087770 | Systemic virotherapy for multiple myeloma |
| Q41919532 | Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses |
| Q55250836 | The wide utility of rabbits as models of human diseases. |
| Q57210671 | Turning cold tumours hot: oncolytic virotherapy gets up close and personal with other therapeutics at the 11th Oncolytic Virus Conference |
Search more.